Web Analytics

Investor Profile

Novo Holdings

Novo Holdings Denmark - Hellerup, Gentofte
INVESTOR

1 Disclosed Funding Rounds $50,000,000
34 Participating Investments




Novo Holdings is a holding and investment company, responsible for managing the operating and financial assets of the Novo Nordisk Foundation. Headquartered in Copenhagen and wholly owned b

Invested In

Company Date Round Raised
  Avalyn Pharma Inc. September, 28 ,2023 Series C $175,000,000
  MEDGENOME September, 03 ,2022 Unknown $50,000,000
  Hemab Therapeutics February, 22 ,2023 Series B $135,000,000
  MapLight Therapeutics, Inc. October, 31 ,2023 Series C $225,000,000
  Qure.ai March, 29 ,2022 Series C $40,000,000
  Hoba Therapeutics December, 12 ,2023 Series A $24,800,000
  AMSilk GmbH | Biotech Materials April, 05 ,2023 Unknown $27,344,000
  Nalu Medical, Inc. January, 05 ,2024 Unknown $65,000,000
  Ray Therapeutics, Inc. May, 17 ,2023 Series A $100,000,000
  Cleveland Diagnostics, Inc. January, 18 ,2024 Unknown $75,000,000
  Octave June, 16 ,2023 Series C $52,000,000
  Elo Life Systems January, 25 ,2024 Series A $20,500,000
  Halodoc August, 02 ,2023 Series D $100,000,000
  CARPL - Radiology AI Platform February, 02 ,2024 Unknown $6,000,000
  Bactolife August, 14 ,2023 Series A $30,000,000
  Avalyn Pharma Inc. September, 28 ,2023 Series C $175,000,000
  Bluejay Therapeutics May, 10 ,2024 Series C $182,000,000
  MapLight Therapeutics, Inc. October, 31 ,2023 Series C $225,000,000
  Myricx Bio July, 09 ,2024 Series A $115,246,800
  Hoba Therapeutics December, 12 ,2023 Series A $24,800,000
  F2G September, 13 ,2024 Unknown $100,000,000
  Nalu Medical, Inc. January, 05 ,2024 Unknown $65,000,000
  Booster Therapeutics October, 11 ,2024 Seed $15,000,000
  Cleveland Diagnostics, Inc. January, 18 ,2024 Unknown $75,000,000
  Elo Life Systems January, 25 ,2024 Series A $20,500,000
  AvenCell October, 22 ,2024 Series B $112,000,000
  CARPL - Radiology AI Platform February, 02 ,2024 Unknown $6,000,000
  Adcendo November, 26 ,2024 Series B $135,000,000
  Bluejay Therapeutics May, 10 ,2024 Series C $182,000,000
  Myricx Bio July, 09 ,2024 Series A $115,246,800
  F2G September, 13 ,2024 Unknown $100,000,000
  Booster Therapeutics October, 11 ,2024 Seed $15,000,000
  AvenCell October, 22 ,2024 Series B $112,000,000
  Adcendo November, 26 ,2024 Series B $135,000,000